FilingSEC EDGAR8-K
BioCardia to Present at Investor Conference
· SEC accepted
StageScheduled Presentation
Filing content
BioCardia's CEO will present the company's clinical and technology development progress at the H.C. Wainwright investor conference.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…